XML 97 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Options and Stock Appreciation Rights - SARs (Details) - Stock Appreciation Rights (SARs) - USD ($)
12 Months Ended
Apr. 18, 2022
Dec. 31, 2023
Dec. 31, 2022
Stock option details      
Shares available for future grants 750,000    
Maximum exercisable period for granted share-based compensation 10 years    
Number of rights issued   465,250  
Vesting period 8 years    
SARs      
Outstanding beginning balance   489,250  
Granted   465,250  
Forfeited   (24,000)  
Outstanding ending balance   465,250 489,250
Weighted average exercise price      
Weighted average exercise price, beginning balance (per share)   $ 39.35  
Weighted average exercise price, forfeited (per share)   39.33  
Weighted average exercise price, ending balance (per share)   $ 39.35 $ 39.35
Aggregate intrinsic value      
Aggregate intrinsic value   $ 6,964,000  
Weighted average remaining contractual term (years)   8 years 6 months  
Fair Value of Liability   $ 1,464,000 $ 546,000
Stock-based compensation expense   918,000 $ 546,000
Stock-based compensation cost, unrecognized   $ 5,090,000  
Stock-based compensation cost, unrecognized, weighted-average period of recognition   8 years 6 months